Lance Baldo

Biotech executive and CEO of Beacon Therapeutics, experienced in ophthalmology drug development with prior roles at Roche and Genentech and leading gene-therapy programs for inherited retinal disease.

Best podcasts with Lance Baldo

Ranked by the Snipd community

10 snips

Dec 16, 2025 • 16min

Episode 100 - Lance Baldo - CEO of Beacon Therapeutics

Lance Baldo, CEO of Beacon Therapeutics and seasoned biotech executive, shares insights from his impressive career in ophthalmology. He discusses the VISTA phase-3 trial of laru-zova, an AAV gene therapy for X-Linked Retinitis Pigmentosa, detailing its promising progress and expected results in 2026. Lance delves into the challenges of transitioning to CEO, and emphasizes the importance of team dynamics and regulatory strategies. His journey from medicine to biotech highlights his commitment to innovation and patient impact in treating blinding diseases.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app